Stay updated with breaking news from Glenmark Specialty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glenmark Pharma soared as management's bullish FY25 targets offset weak quarterly earnings. Despite widening losses due to impairment charges, adjusted net profit nearly tripled, driven by a stake sale in Glenmark Life Sciences.
Glenmark Specialty SA partners with BeiGene to bring innovative oncology drugs to India, addressing rising cancer rates.
Science News: Glenmark Specialty SA, a subsidiary of Glenmark Pharma, announced an exclusive marketing and distribution agreement with BeiGene, a global oncology co.
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.
Mumbai: Cosmo Pharmaceuticals N.V. and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. have announced the signing of distribution and license agreements for Winlevi...